Literature DB >> 9299419

Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells.

C K Sen1, S Khanna, A Z Reznick, S Roy, L Packer.   

Abstract

TNF alpha is implicated in several skeletal muscle pathologies including muscle wasting of cachexia. Muscle wasting and other conditions such as physical exercise and immobilization are also associated with disturbances in muscle glutathione status. Hence, it was of interest to investigate the role of endogenous glutathione status in TNF alpha induced NF-kappa B activation in skeletal muscle-derived cells. TNF alpha proved to be a potent inducer of transient NF-kappa B activation in L6 myoblasts. In buthioninesulfoximine (BSO) treated cells, TNF alpha induced NF-kappa B activation was markedly potentiated suggesting that such activation is sensitive to cellular GSH, but may have been independent of high levels of intracellular GSSG. Because this activation was inhibited by the antioxidant pyrrolidinedithiocarbamate (PDTC) the involvement of reactive oxygen species in this activation system seems likely. NF-kappa B activation in L6 cells was also observed in response to direct H2O2 treatment. Results from GSSG reductase inhibited cells suggest that GSSG may participate in, but is not required for, TNF alpha induced NF-kappa B activation. The inhibitory effect of PDTC on NF-kappa B activation correlated with its effect on ICAM-1 expression suggesting that this GSH status modifying agent not only influenced nuclear translocation of NF-kappa B proteins but also regulated kappa B dependent transcription.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299419     DOI: 10.1006/bbrc.1997.7206

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Nutritional therapy for cancer cachexia.

Authors:  R F Grimble
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

2.  X-linked vacuolated myopathy : TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma.

Authors:  K Rouger; J P Louboutin; M Villanova; Y Cherel; M Fardeau
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury.

Authors:  Praveen Mannam; Xuchen Zhang; Peiying Shan; Yi Zhang; Amanda S Shinn; Yitao Zhang; Patty J Lee
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

Review 4.  Glutathione homeostasis in response to exercise training and nutritional supplements.

Authors:  C K Sen
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 5.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 6.  Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation.

Authors:  P O Hasselgren; J E Fischer
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

7.  The involvement of oxidants and NF-κB in cytokine-induced MMP-9 synthesis by bone marrow-derived osteoprogenitor cells.

Authors:  Dror Ben-David; Erella Livne; Abraham Z Reznick
Journal:  Inflamm Res       Date:  2012-03-13       Impact factor: 4.575

8.  Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.

Authors:  Esther Ardite; Joan Albert Barbera; Josep Roca; Jose C Fernández-Checa
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 9.  Reactive oxygen species: impact on skeletal muscle.

Authors:  Scott K Powers; Li Li Ji; Andreas N Kavazis; Malcolm J Jackson
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.